Distribution of autosomal fragile sites in specimens cultured for prenatal fragile X diagnosis

We reviewed the distribution of autosomal fragile sites (FS) and spontaneous chromosome breaks or gaps (CB) at chromosome locations other than those recognized as FS from 100 amniotic fluid samples (AF), 19 chorionic villus samples (CVS), and 5 percutaneous umbilical blood samples (PUBS) referred fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of medical genetics 1991-02, Vol.38 (2-3), p.456-463
Hauptverfasser: Krawczun, Michael S., Jenkins, Edmund C., Duncan, Charlotte J., Stark-Houck, Sandra L., Kunaporn, Suphat, Schwartz-Richstein, Carol, Gu, Hong, Brown, W. Ted
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 463
container_issue 2-3
container_start_page 456
container_title American journal of medical genetics
container_volume 38
creator Krawczun, Michael S.
Jenkins, Edmund C.
Duncan, Charlotte J.
Stark-Houck, Sandra L.
Kunaporn, Suphat
Schwartz-Richstein, Carol
Gu, Hong
Brown, W. Ted
description We reviewed the distribution of autosomal fragile sites (FS) and spontaneous chromosome breaks or gaps (CB) at chromosome locations other than those recognized as FS from 100 amniotic fluid samples (AF), 19 chorionic villus samples (CVS), and 5 percutaneous umbilical blood samples (PUBS) referred for fragile X [fra(X)] analysis. We present data on the degree of expression of autosomal fragility in AF, CVS, and PUBS samples, and the relationship between degree of expression and induction system. The most common observed FS were: 3p14, 9p32, and 6q26 in AF; 9q32, 3q27, and 8q22 in CVS; and 3p14, Xq22, and 16q23 in PUBS cases. Distribution of FS and CB, when compared by induction system, was not found to be identical. Our data also indicate that the presence of any particular FS cannot be used as an indicator for the effectiveness of the fra(X) induction system in prenatal samples.
doi_str_mv 10.1002/ajmg.1320380264
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80519182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80519182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4424-ba21b437de8472dc1750f333d3eb016674d35f2d028334860befa1607b6834e3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1EVZbCmROSD4hb2vFHbEecqhQWUCkSqlROWE7irFySePEkgv57XO1qoaeeRvI878zoMSGvGJwyAH7mbsfNKRMchAGu5BOyYlCpwihunpIVMGkKzavqGXmOeAvA8gM_JsccmAGjV-THRcA5hWaZQ5xo7Klb5ohxdAPtk9uEwVMMs0caJopb34bRT0jbZZiX5Dvax0S3yU9u_i_wnXbBbaaIAV-Qo94N6F_u6wm5_vD-uv5YXH5df6rPL4tWSi6LxnHWSKE7b6TmXct0Cb0QohO-AaaUlp0oe94BN0JIo6DxvWMKdKOMkF6ckLe7sdsUfy0eZzsGbP0wuMnHBa2BklXM8EdBVmZzFVQZPNuBbYqIyfd2m8Lo0p1lYO_N23vz9p_5nHi9H700o-8O_F517r_Z9x22bsiypjbgASslE1qqjL3bYb-zyrvHttrzz1_WD44odun8q_7PIe3ST6u00KW9uVrbK6gv2Le6tjfiLwvbrB4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15862909</pqid></control><display><type>article</type><title>Distribution of autosomal fragile sites in specimens cultured for prenatal fragile X diagnosis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Krawczun, Michael S. ; Jenkins, Edmund C. ; Duncan, Charlotte J. ; Stark-Houck, Sandra L. ; Kunaporn, Suphat ; Schwartz-Richstein, Carol ; Gu, Hong ; Brown, W. Ted</creator><creatorcontrib>Krawczun, Michael S. ; Jenkins, Edmund C. ; Duncan, Charlotte J. ; Stark-Houck, Sandra L. ; Kunaporn, Suphat ; Schwartz-Richstein, Carol ; Gu, Hong ; Brown, W. Ted</creatorcontrib><description>We reviewed the distribution of autosomal fragile sites (FS) and spontaneous chromosome breaks or gaps (CB) at chromosome locations other than those recognized as FS from 100 amniotic fluid samples (AF), 19 chorionic villus samples (CVS), and 5 percutaneous umbilical blood samples (PUBS) referred for fragile X [fra(X)] analysis. We present data on the degree of expression of autosomal fragility in AF, CVS, and PUBS samples, and the relationship between degree of expression and induction system. The most common observed FS were: 3p14, 9p32, and 6q26 in AF; 9q32, 3q27, and 8q22 in CVS; and 3p14, Xq22, and 16q23 in PUBS cases. Distribution of FS and CB, when compared by induction system, was not found to be identical. Our data also indicate that the presence of any particular FS cannot be used as an indicator for the effectiveness of the fra(X) induction system in prenatal samples.</description><identifier>ISSN: 0148-7299</identifier><identifier>EISSN: 1096-8628</identifier><identifier>DOI: 10.1002/ajmg.1320380264</identifier><identifier>PMID: 2018087</identifier><identifier>CODEN: AJMGDA</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Amniotic Fluid - cytology ; autosomal fragility ; Biological and medical sciences ; Cells, Cultured ; Chorionic Villi - ultrastructure ; Chromosome Fragile Sites ; Chromosome Fragility ; Female ; Fetal Blood - cytology ; Fragile X Syndrome - diagnosis ; Fragile X Syndrome - pathology ; fragile(X)(q27) ; Humans ; Lymphocytes - ultrastructure ; Male ; Medical genetics ; Medical sciences ; Pregnancy ; Prenatal Diagnosis</subject><ispartof>American journal of medical genetics, 1991-02, Vol.38 (2-3), p.456-463</ispartof><rights>Copyright © 1991 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1992 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4424-ba21b437de8472dc1750f333d3eb016674d35f2d028334860befa1607b6834e3</citedby><cites>FETCH-LOGICAL-c4424-ba21b437de8472dc1750f333d3eb016674d35f2d028334860befa1607b6834e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5413746$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2018087$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krawczun, Michael S.</creatorcontrib><creatorcontrib>Jenkins, Edmund C.</creatorcontrib><creatorcontrib>Duncan, Charlotte J.</creatorcontrib><creatorcontrib>Stark-Houck, Sandra L.</creatorcontrib><creatorcontrib>Kunaporn, Suphat</creatorcontrib><creatorcontrib>Schwartz-Richstein, Carol</creatorcontrib><creatorcontrib>Gu, Hong</creatorcontrib><creatorcontrib>Brown, W. Ted</creatorcontrib><title>Distribution of autosomal fragile sites in specimens cultured for prenatal fragile X diagnosis</title><title>American journal of medical genetics</title><addtitle>Am. J. Med. Genet</addtitle><description>We reviewed the distribution of autosomal fragile sites (FS) and spontaneous chromosome breaks or gaps (CB) at chromosome locations other than those recognized as FS from 100 amniotic fluid samples (AF), 19 chorionic villus samples (CVS), and 5 percutaneous umbilical blood samples (PUBS) referred for fragile X [fra(X)] analysis. We present data on the degree of expression of autosomal fragility in AF, CVS, and PUBS samples, and the relationship between degree of expression and induction system. The most common observed FS were: 3p14, 9p32, and 6q26 in AF; 9q32, 3q27, and 8q22 in CVS; and 3p14, Xq22, and 16q23 in PUBS cases. Distribution of FS and CB, when compared by induction system, was not found to be identical. Our data also indicate that the presence of any particular FS cannot be used as an indicator for the effectiveness of the fra(X) induction system in prenatal samples.</description><subject>Amniotic Fluid - cytology</subject><subject>autosomal fragility</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Chorionic Villi - ultrastructure</subject><subject>Chromosome Fragile Sites</subject><subject>Chromosome Fragility</subject><subject>Female</subject><subject>Fetal Blood - cytology</subject><subject>Fragile X Syndrome - diagnosis</subject><subject>Fragile X Syndrome - pathology</subject><subject>fragile(X)(q27)</subject><subject>Humans</subject><subject>Lymphocytes - ultrastructure</subject><subject>Male</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Pregnancy</subject><subject>Prenatal Diagnosis</subject><issn>0148-7299</issn><issn>1096-8628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi1EVZbCmROSD4hb2vFHbEecqhQWUCkSqlROWE7irFySePEkgv57XO1qoaeeRvI878zoMSGvGJwyAH7mbsfNKRMchAGu5BOyYlCpwihunpIVMGkKzavqGXmOeAvA8gM_JsccmAGjV-THRcA5hWaZQ5xo7Klb5ohxdAPtk9uEwVMMs0caJopb34bRT0jbZZiX5Dvax0S3yU9u_i_wnXbBbaaIAV-Qo94N6F_u6wm5_vD-uv5YXH5df6rPL4tWSi6LxnHWSKE7b6TmXct0Cb0QohO-AaaUlp0oe94BN0JIo6DxvWMKdKOMkF6ckLe7sdsUfy0eZzsGbP0wuMnHBa2BklXM8EdBVmZzFVQZPNuBbYqIyfd2m8Lo0p1lYO_N23vz9p_5nHi9H700o-8O_F517r_Z9x22bsiypjbgASslE1qqjL3bYb-zyrvHttrzz1_WD44odun8q_7PIe3ST6u00KW9uVrbK6gv2Le6tjfiLwvbrB4</recordid><startdate>19910201</startdate><enddate>19910201</enddate><creator>Krawczun, Michael S.</creator><creator>Jenkins, Edmund C.</creator><creator>Duncan, Charlotte J.</creator><creator>Stark-Houck, Sandra L.</creator><creator>Kunaporn, Suphat</creator><creator>Schwartz-Richstein, Carol</creator><creator>Gu, Hong</creator><creator>Brown, W. Ted</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T3</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19910201</creationdate><title>Distribution of autosomal fragile sites in specimens cultured for prenatal fragile X diagnosis</title><author>Krawczun, Michael S. ; Jenkins, Edmund C. ; Duncan, Charlotte J. ; Stark-Houck, Sandra L. ; Kunaporn, Suphat ; Schwartz-Richstein, Carol ; Gu, Hong ; Brown, W. Ted</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4424-ba21b437de8472dc1750f333d3eb016674d35f2d028334860befa1607b6834e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Amniotic Fluid - cytology</topic><topic>autosomal fragility</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Chorionic Villi - ultrastructure</topic><topic>Chromosome Fragile Sites</topic><topic>Chromosome Fragility</topic><topic>Female</topic><topic>Fetal Blood - cytology</topic><topic>Fragile X Syndrome - diagnosis</topic><topic>Fragile X Syndrome - pathology</topic><topic>fragile(X)(q27)</topic><topic>Humans</topic><topic>Lymphocytes - ultrastructure</topic><topic>Male</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Pregnancy</topic><topic>Prenatal Diagnosis</topic><toplevel>online_resources</toplevel><creatorcontrib>Krawczun, Michael S.</creatorcontrib><creatorcontrib>Jenkins, Edmund C.</creatorcontrib><creatorcontrib>Duncan, Charlotte J.</creatorcontrib><creatorcontrib>Stark-Houck, Sandra L.</creatorcontrib><creatorcontrib>Kunaporn, Suphat</creatorcontrib><creatorcontrib>Schwartz-Richstein, Carol</creatorcontrib><creatorcontrib>Gu, Hong</creatorcontrib><creatorcontrib>Brown, W. Ted</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Human Genome Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of medical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krawczun, Michael S.</au><au>Jenkins, Edmund C.</au><au>Duncan, Charlotte J.</au><au>Stark-Houck, Sandra L.</au><au>Kunaporn, Suphat</au><au>Schwartz-Richstein, Carol</au><au>Gu, Hong</au><au>Brown, W. Ted</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distribution of autosomal fragile sites in specimens cultured for prenatal fragile X diagnosis</atitle><jtitle>American journal of medical genetics</jtitle><addtitle>Am. J. Med. Genet</addtitle><date>1991-02-01</date><risdate>1991</risdate><volume>38</volume><issue>2-3</issue><spage>456</spage><epage>463</epage><pages>456-463</pages><issn>0148-7299</issn><eissn>1096-8628</eissn><coden>AJMGDA</coden><abstract>We reviewed the distribution of autosomal fragile sites (FS) and spontaneous chromosome breaks or gaps (CB) at chromosome locations other than those recognized as FS from 100 amniotic fluid samples (AF), 19 chorionic villus samples (CVS), and 5 percutaneous umbilical blood samples (PUBS) referred for fragile X [fra(X)] analysis. We present data on the degree of expression of autosomal fragility in AF, CVS, and PUBS samples, and the relationship between degree of expression and induction system. The most common observed FS were: 3p14, 9p32, and 6q26 in AF; 9q32, 3q27, and 8q22 in CVS; and 3p14, Xq22, and 16q23 in PUBS cases. Distribution of FS and CB, when compared by induction system, was not found to be identical. Our data also indicate that the presence of any particular FS cannot be used as an indicator for the effectiveness of the fra(X) induction system in prenatal samples.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>2018087</pmid><doi>10.1002/ajmg.1320380264</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0148-7299
ispartof American journal of medical genetics, 1991-02, Vol.38 (2-3), p.456-463
issn 0148-7299
1096-8628
language eng
recordid cdi_proquest_miscellaneous_80519182
source MEDLINE; Alma/SFX Local Collection
subjects Amniotic Fluid - cytology
autosomal fragility
Biological and medical sciences
Cells, Cultured
Chorionic Villi - ultrastructure
Chromosome Fragile Sites
Chromosome Fragility
Female
Fetal Blood - cytology
Fragile X Syndrome - diagnosis
Fragile X Syndrome - pathology
fragile(X)(q27)
Humans
Lymphocytes - ultrastructure
Male
Medical genetics
Medical sciences
Pregnancy
Prenatal Diagnosis
title Distribution of autosomal fragile sites in specimens cultured for prenatal fragile X diagnosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A28%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distribution%20of%20autosomal%20fragile%20sites%20in%20specimens%20cultured%20for%20prenatal%20fragile%20X%20diagnosis&rft.jtitle=American%20journal%20of%20medical%20genetics&rft.au=Krawczun,%20Michael%20S.&rft.date=1991-02-01&rft.volume=38&rft.issue=2-3&rft.spage=456&rft.epage=463&rft.pages=456-463&rft.issn=0148-7299&rft.eissn=1096-8628&rft.coden=AJMGDA&rft_id=info:doi/10.1002/ajmg.1320380264&rft_dat=%3Cproquest_cross%3E80519182%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15862909&rft_id=info:pmid/2018087&rfr_iscdi=true